Thus, MFN2 overexpression leads to increased interactions between mitochondria and endoplasmic reticulum, causing enhanced mitochondrial clearance and resistance to VEN, which in the abovementioned cell background of mitophagy, cannot function as an effective drug in AML (93). Here, MFN2 is linked to acute myeloid leukemia.